Investigational Drug Information for Talnetant
✉ Email this page to a colleague
What is the development status for investigational drug Talnetant?
Talnetant is an investigational drug.
There have been 4 clinical trials for Talnetant.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2004.
The most common disease conditions in clinical trials are Schizophrenia, Irritable Bowel Syndrome, and [disabled in preview]. The leading clinical trial sponsors are GlaxoSmithKline and [disabled in preview].
Summary for Talnetant
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,464 |
| WIPO Patent Applications | 600 |
| Japanese Patent Applications | 327 |
| Clinical Trial Progress | Phase 2 (2004-12-01) |
| Vendors | 57 |
Recent Clinical Trials for Talnetant
| Title | Sponsor | Phase |
|---|---|---|
| Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia | GlaxoSmithKline | Phase 2 |
| Effect Of Talnetant Versus Risperidone Versus Placebo On Psychotic Symptoms In Schizophrenic Patients | GlaxoSmithKline | Phase 2 |
| Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS) | GlaxoSmithKline | Phase 2 |
Clinical Trial Summary for Talnetant
Top disease conditions for Talnetant
Top clinical trial sponsors for Talnetant
US Patents for Talnetant
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
